,aspect=ignore)
Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
*Information on this page should not be used to diagnose, prevent, treat or cure any disease or condition
In March 2011, the FDA placed the trial on clinical hold due to GMP compliance issues at the contract manufacturer not safety concerns with RGN-352 itself
Therefore, therapies based on antioxidants and/or vasodilators have been postulated as strategies to prevent and/or reduce the progression of NIHL in several animal models and humans
This capsule format gives researchers a clearly defined composition for laboratory research workflows while maintaining a strict research-use-only positioning
Received: Accepted: Published: Issue date: DOI:
2024AAC03224, 2023AAC02037, 2023AAC03176, and 2022AAC03179), as well as the General Project of Scientific Research Projects in Ningxia Higher-education Institutions (grant no
US$ 22.42
US$ 24.26
US$ 29.78
